PNOĒ, a company based in Malden, Massachusetts, and Athens, Greece, is launching its PNOĒ 2.0 device on October 1. The primary new feature is the ability for users to self-administer metabolic breath tests. This eliminates the need for a trained operator, a requirement of the previous model.
Co-founder and CEO Apostolos Atsalakis stated that users can simply wear the mask, press a button, and breathe for eight minutes to complete a test. This simplified process is intended to allow the device to be used in locations such as fitness centers without dedicated staff, and potentially pharmacies.
Metabolic testing, which analyzes breath gases to assess energy production and measure VO₂ max, has historically required expensive, bulky equipment found in specialized labs. PNOĒ aims to provide the same accuracy in a portable device, paired with software that translates results into personalized recommendations for diet and training. The device captures 23 biomarkers, including resting metabolic rate and metabolic flexibility.
Atsalakis highlights that these metrics can answer questions about caloric needs and optimal training methods that blood tests cannot. The timing of the launch coincides with increased interest in VO₂ max among longevity enthusiasts.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's briefNew every morning, and the back catalogue is archived by date.
PNOĒ is releasing the PNOĒ 2.0, a new version of its metabolic breath testing device that allows users to administer tests themselves. This change aims to make lab-grade metabolic analysis, traditionally limited to elite athletes and medical settings, more accessible to a wider audience in fitness centers and potentially pharmacies.